# Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

> **NCT00003597** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 16 (actual)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** recombinant human thrombopoietin
- **DRUG:** carboplatin
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **BIOLOGICAL:** G-CSF

## Key facts

- **NCT ID:** NCT00003597
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** 2004-10
- **Final completion:** 2005-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003597, "Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*